$ASIX

AdvanSix Inc. (ASIX): Results of Operations and Financial Condition

AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99q22026prearningsa.htm EX-99.1 Document Exhibit 99.1 News Release ADVANSIX ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS 2Q26 Sales of $421 million, up 3% versus prior year 2Q26 Earnings Per Share of $0.12; Adjusted Earnings Per Share of $0.19 2Q26 Cash Flow f

Original reporting
Published Aug 7, 2026, 10:29 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ASIX
Bearish
high confidence
Mentioned
$ASIX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ASIXBearishMed
01

Why it matters

Key trading inputs are the magnitude of YoY declines in net income, adjusted EBITDA, and operating cash flow, plus management’s 3Q26 sequential pricing expectation for ammonium sulfate and a 2H26 cash-flow improvement plan tied to capex and working capital.

02

Market read

Traders will likely reprice ASIX around margin and cash-flow deterioration in Plant Nutrients, while also weighing management’s guidance for sequential pricing and 2H26 cash-flow improvement.

03

What to watch

Plant Nutrients volume fell short due to farmer economics, so the market may be over-weighting demand weakness versus potential normalization; also 45Q carbon capture tax credits timing affected prior-year comparability and could distort trend interpretation.

Relevance 7/10Novelty 8/10Timing: pre-market today (8/7) with same-day earnings release and dividend record/payment dates

Background

This is an SEC 8-K filing with Exhibit 99.1 covering AdvanSix’s second quarter 2026 results and forward-looking outlook, including a declared quarterly dividend and conference call details.

Company-level read

Ticker impact

$ASIXBearishHigh confidence
Context

AdvanSix reported 2Q26 sales of $421.3M (+3% YoY) but sharply lower net income and adjusted EBITDA, plus 3Q26 outlook on ammonium sulfate pricing.

Expected impact

Near-term bias likely negative as traders focus on weaker earnings/cash flow and the expectation of 3Q26 sequential pricing decline, despite some offsetting pricing tailwinds.

Evidence & confidence

The filing provides concrete quarterly P&L and cash-flow deltas versus prior year, and it includes specific forward-looking statements for 3Q26 pricing dynamics and 2H26 cash-flow improvement drivers.

Market effects

Plant Nutrients and fertilizer input pricing dynamics (ammonium sulfate, sulfur costs) are highlighted, which can influence sentiment across adjacent ag-chem and industrial chemical names.

Primarily North American fertilizer supply chain exposure via ammonium sulfate fill program and domestic pricing expectations.

Limited direct global read-through, but benzene/propylene and nitrogen pricing references can matter for broader chemical input cost expectations.

Counterpoint

The company emphasizes pricing mechanisms and expects 2H26 cash-flow improvement from reduced capex run-rate and working-capital tailwinds, which could offset near-term earnings weakness.

Key entities

  • AdvanSix Inc.

    Vertically integrated chemistry company reporting 2Q26 financial results and 2026 outlook, including dividend declaration.

  • Erin Kane

    CEO quoted on performance drivers and outlook.

Related articles

$ASIXMed

AdvanSix Inc. Q2 2026 Earnings Call Summary

AdvanSix Inc. reported Q2 2026 sequential earnings improvement, citing raw material costs shifting from a $10 million headwind in Q1 to a $39 million tailwind in Q2, and fully offsetting $72 million in YoY raw material headwinds via pricing. It noted lower plant nutrient volumes, near-record domestic granular ammonium sulfate volumes, and expects sequential EBITDA and cash flow improvement in H2 2026.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.